Itochu Corp has entered into an alliance with three Australian researchinstitutes, with the aim of marketing their biotechnology products in Japan, according to the Nihon Keizai Shimbun. The three institutes include two state-affiliated groups - the Commonwealth Scientific and Industrial Research Organization and the Australian Institute of Marine Science - as well as the Institute for Molecular Bioscience.
Principally, Itochu will market biotechnology software for genetic diagnosis and protein analysis, developed by the CSIRO and the IMB, to Japanese pharmaceutical firms. It is the first time that Itochu has linked up with a foreign institute in the biotechnology field.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze